Previous reports have shown that the Hippo pathway was deregulated and TAZ was activated in a broad range of human cancers, which was often correlated with poor patient prognosis, including lung, colorectal, ovarian, liver and prostate cancers [12, 16, 22, 30, 35–40]. This evidence concerns the gene WWTR1 and Familial prostate cancer.